Cash flow Bio-Rad Laboratories, Inc.

Stocks

BIO

US0905722072

Medical Equipment, Supplies & Distribution

Market Closed - NYSE Other stock markets 00:00:02 30/06/2026 +04			Pre-market 17:16:47
295.30 ^USD	-1.83%		279.14	-5.47%

06-03	Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM
05-19	Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 08:30 AM

8a269d3f5cc668fe896a13faeb6.OvtfTPvZp2ACoYbpHRZv95LfEKqhImi5_Vx95yFca_E.W8MVHKOIzRk24NyOKVQ5sPqYeM7OTCXmmmwTuBBsMYkMvGw4mfTjKEnm8Q

Published financial data: BIO-RAD LABORATORIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	2.92B	2.8B	2.67B	2.57B	2.58B
Total Revenues	2.92B	2.8B	2.67B	2.57B	2.58B
Cost of Goods Sold, Total	1.26B	1.23B	1.24B	1.19B	1.24B
Gross Profit	1.67B	1.57B	1.43B	1.38B	1.34B
Selling General & Admin Expenses, Total	853M	825M	824M	814M	820M
R&D Expenses	258M	257M	241M	296M	258M
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	1.11B	1.08B	1.07B	1.11B	1.08B
Operating Income	554M	487M	366M	269M	266M
Interest Expense, Total	-1.55M	-38.11M	-49.44M	-48.9M	-49M
Interest And Investment Income	18.9M	58M	101M	82M	95.5M
Net Interest Expenses	17.35M	19.89M	51.46M	33.1M	46.5M
Currency Exchange Gains (Loss)	-2.75M	205K	7.35M	3.9M	6.6M
Other Non Operating Income (Expenses)	375K	-5.33M	4.84M	1.6M	-300K
EBT, Excl. Unusual Items	569M	502M	429M	308M	319M
Restructuring Charges	-64.4M	-4.2M	-27.9M	-	-46.1M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	4.93B	-5.2B	-1.25B	-2.65B	895M
Gain (Loss) On Sale Of Assets	-	1.4M	-	-	-
Asset Writedown	-	-	-	-	-173M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	5.44B	-4.7B	-850M	-2.34B	996M
Income Tax Expense	1.19B	-1.08B	-213M	-498M	236M
Earnings From Continuing Operations	4.25B	-3.63B	-637M	-1.84B	760M
Net Income to Company	4.25B	-3.63B	-637M	-1.84B	760M
Net Income - (IS)	4.25B	-3.63B	-637M	-1.84B	760M
Net Income to Common Incl Extra Items	4.25B	-3.63B	-637M	-1.84B	760M
Net Income to Common Excl. Extra Items	4.25B	-3.63B	-637M	-1.84B	760M
Per Share Items
Net EPS - Basic	142.33	-121.79	-21.82	-65.36	27.85
Basic EPS - Continuing Operations	142.33	-121.79	-21.82	-65.36	27.85
Basic Weighted Average Shares Outstanding	29.83M	29.78M	29.21M	28.21M	27.28M
Net EPS - Diluted	140.56	-121.79	-21.82	-65.36	27.85
Diluted EPS - Continuing Operations	140.56	-121.79	-21.82	-65.36	27.85
Diluted Weighted Average Shares Outstanding	30.21M	29.78M	29.21M	28.21M	27.28M
Normalized Basic EPS	11.92	10.53	9.19	6.81	7.31
Normalized Diluted EPS	11.77	10.53	9.19	6.81	7.31
Supplemental Items
EBITDA	688M	624M	512M	421M	432M
EBITA	583M	512M	389M	290M	290M
EBIT	554M	487M	366M	269M	266M
EBITDAR	738M	679M	575M	490M	498M
Effective Tax Rate - (Ratio)	21.92	22.89	25.03	21.27	23.67
Current Domestic Taxes	81.6M	133M	85.8M	95M	45.3M
Current Foreign Taxes	32.6M	24.1M	17.4M	28.5M	17.7M
Total Current Taxes	114M	157M	103M	124M	63M
Deferred Domestic Taxes	1.05B	-1.2B	-307M	-606M	193M
Deferred Foreign Taxes	32.1M	-36.7M	-15.2M	-20.5M	-22.3M
Total Deferred Taxes	1.08B	-1.24B	-323M	-627M	170M
Normalized Net Income	356M	314M	268M	192M	199M
Interest on Long-Term Debt	800K	800K	700K	700K	700K
Non-Cash Pension Expense	600K	-400K	2M	2.8M	1.8M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	275M	257M	247M	296M	276M
Net Rental Expense, Total	50.2M	54.5M	63.4M	69.5M	66.9M
Imputed Operating Lease Interest Expense	2.77M	20.62M	17.95M	19.56M	19.01M
Imputed Operating Lease Depreciation	47.43M	33.88M	45.45M	49.94M	47.89M
Stock-Based Comp., COGS (Total)	4.9M	5.4M	6.1M	6.5M	6.3M
Stock-Based Comp., R&D Exp. (Total)	8.3M	9.9M	11.3M	12.9M	11.4M
Stock-Based Comp., SG&A Exp. (Total)	38M	45.6M	43.9M	42.9M	40.3M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	51.2M	60.9M	61.3M	62.3M	58M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	471M	434M	404M	488M	530M
Short Term Investments	399M	1.36B	1.2B	1.18B	1.01B
Total Cash And Short Term Investments	870M	1.79B	1.61B	1.66B	1.54B
Accounts Receivable, Total	424M	495M	489M	452M	461M
Other Receivables	2.2M	11.6M	11.9M	13.1M	11.9M
Total Receivables	426M	506M	501M	466M	472M
Inventory	572M	719M	781M	760M	741M
Prepaid Expenses	108M	124M	140M	123M	136M
Restricted Cash	14K	13K	151K	1.4M	2M
Other Current Assets, Total	13.44M	17.55M	19.56M	16.2M	13.8M
Total Current Assets	1.99B	3.16B	3.05B	3.03B	2.91B
Gross Property Plant And Equipment	1.69B	1.69B	1.79B	1.8B	1.97B
Accumulated Depreciation	-998M	-1.01B	-1.07B	-1.11B	-1.26B
Net Property Plant And Equipment	696M	680M	724M	689M	710M
Long-term Investments	14.39B	8.83B	7.7B	4.84B	6.1B
Goodwill	347M	406M	414M	410M	580M
Other Intangibles, Total	254M	332M	321M	294M	174M
Other Long-Term Assets, Total	104M	95.8M	96.35M	104M	104M
Total Assets	17.78B	13.5B	12.3B	9.36B	10.58B
Liabilities
Accounts Payable, Total	142M	135M	145M	122M	129M
Accrued Expenses, Total	313M	215M	140M	124M	172M
Current Portion of Long-Term Debt	-	-	-	800K	800K
Current Portion of Leases	36.92M	36.8M	40.86M	42.1M	36.6M
Current Income Taxes Payable	10.32M	11.93M	35.76M	31.2M	36.6M
Unearned Revenue Current, Total	50.85M	52.21M	-	-	48.9M
Other Current Liabilities	128M	117M	162M	147M	92.8M
Total Current Liabilities	681M	569M	523M	468M	517M
Long-Term Debt	14K	1.19B	1.19B	1.19B	1.19B
Long-Term Leases	186M	164M	175M	141M	154M
Unearned Revenue Non Current	-	-	-	-	14M
Pension & Other Post Retirement Benefits	73.8M	45.3M	59.5M	56.9M	49.2M
Deferred Tax Liability Non Current	3.06B	1.77B	1.48B	818M	1.06B
Other Non Current Liabilities	108M	151M	136M	120M	136M
Total Liabilities	4.11B	3.89B	3.56B	2.79B	3.12B
Common Stock, Total	3K	3K	3K	-	-
Additional Paid In Capital	442M	447M	449M	463M	476M
Retained Earnings	13.51B	9.9B	9.26B	7.42B	8.18B
Treasury Stock	-106M	-264M	-633M	-772M	-1.01B
Comprehensive Income and Other	-176M	-467M	-336M	-538M	-189M
Total Common Equity	13.67B	9.62B	8.74B	6.57B	7.45B
Total Equity	13.67B	9.62B	8.74B	6.57B	7.45B
Total Liabilities And Equity	17.78B	13.5B	12.3B	9.36B	10.58B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	29.93M	29.6M	28.52M	28.01M	26.99M
ECS Total Common Shares Outstanding	29.93M	29.6M	28.52M	28.01M	26.99M
Book Value / Share	456.6	324.89	306.51	234.52	276.16
Tangible Book Value	13.07B	8.88B	8.01B	5.87B	6.7B
Tangible Book Value Per Share	436.51	299.93	280.77	209.39	248.22
Total Debt	223M	1.39B	1.41B	1.37B	1.38B
Net Debt	-647M	-403M	-202M	-290M	-156M
Debt Equivalent of Unfunded Proj. Benefit Obligation	76.1M	46.8M	62.2M	59.2M	57.6M
Debt Equivalent Oper. Leases	402M	436M	507M	556M	535M
Equity Method Investments, Total	59.1M	26.7M	32.3M	27.9M	36.9M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	117M	229M	232M	222M	212M
Inventories - Work In Process, Total	143M	221M	246M	243M	235M
Inventories - Finished Goods, Total	313M	270M	303M	295M	293M
Land - (BS)	27.94M	27.8M	28.4M	27.8M	28.9M
Buildings, Total	386M	394M	420M	426M	449M
Machinery, Total	1.07B	1.09B	1.15B	1.18B	1.32B
Full Time Employees	7.9K	8.2K	8.03K	7.7K	7.45K
Accumulated Allowance for Doubtful Accounts (Supple)	15.14M	15.03M	14.93M	9.2M	5.5M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	4.25B	-3.63B	-637M	-1.84B	760M
Depreciation & Amortization - CF	105M	152M	122M	130M	142M
Amortization of Goodwill and Intangible Assets - (CF)	28.4M	24.9M	23.8M	21.2M	23.8M
Depreciation & Amortization, Total	134M	177M	146M	152M	165M
(Gain) Loss From Sale Of Asset	-	-1.4M	-2.5M	-	-
(Gain) Loss on Sale of Investments - (CF)	-4.93B	5.21B	1.25B	2.66B	-894M
Asset Writedown & Restructuring Costs	-	-	-	29.5M	173M
Provision for Credit Losses	-	7.5M	-	-	1.4M
Stock-Based Compensation (CF)	51.2M	60.9M	61.3M	62.3M	58M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	8.82M	-17.76M	-11.98M	20M	-3.3M
Change In Accounts Receivable	-20.4M	-87.4M	11.4M	16.2M	19.6M
Change In Inventories	46.1M	-159M	-46.3M	8.5M	68.9M
Change In Accounts Payable	69.9M	-94.2M	-51.8M	-40.9M	-100K
Change In Income Taxes	-28.8M	-1.2M	-21.3M	24.1M	1.5M
Change In Deferred Taxes	1.08B	-1.24B	-323M	-627M	170M
Change in Other Net Operating Assets	-6.9M	-26.8M	-2.2M	-1.9M	12M
Cash from Operations	657M	194M	375M	455M	532M
Capital Expenditure	-121M	-113M	-157M	-166M	-158M
Sale of Property, Plant, and Equipment	52K	161K	211K	100K	100K
Cash Acquisitions	-126M	-101M	-	-	-218M
Divestitures	-	1.36M	2.5M	-	-
Sale (Purchase) of Intangible assets	-	-1.38M	-	-23.4M	-
Investment in Marketable and Equity Securities, Total	-84.73M	-994M	174M	28.7M	186M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-453M	-	-	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-784M	-1.21B	20.21M	-160M	-190M
Long-Term Debt Issued, Total	-	1.19B	-	-	-
Total Debt Issued	-	1.19B	-	-	-
Long-Term Debt Repaid, Total	-3.02M	-510K	-467K	-400K	-500K
Total Debt Repaid	-3.02M	-510K	-467K	-400K	-500K
Issuance of Common Stock	20.63M	17.56M	18.48M	19.2M	15.8M
Repurchase of Common Stock	-72.48M	-230M	-444M	-207M	-298M
Other Financing Activities, Total	-561K	-48K	-	-30.6M	-
Cash from Financing	-55.43M	974M	-426M	-219M	-283M
Foreign Exchange Rate Adjustments	-12.64M	2.98M	321K	9.2M	-16.9M
Miscellaneous Cash Flow Adjustments	-	47K	43K	-	-
Net Change in Cash	-196M	-36.59M	-30.18M	85.4M	42.4M
Supplemental Items
Cash Income Tax Paid (Refund)	135M	158M	130M	99.4M	61.6M
Levered Free Cash Flow	490M	45.59M	124M	181M	257M
Unlevered Free Cash Flow	491M	69.42M	155M	211M	287M
Change In Net Working Capital	-80.33M	359M	124M	-18.4M	-55M
Net Debt Issued / Repaid	-3.02M	1.19B	-467K	-400K	-500K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.25	1.94	1.77	1.55	1.67
Return on Total Capital	2.89	2.44	2.16	1.86	1.98
Return On Equity %	36.06	-31.14	-6.94	-24.09	10.84
Return on Common Equity	36.06	-31.14	-6.94	-24.09	10.84
Margin Analysis
Gross Profit Margin %	56.99	55.97	53.56	53.73	52.01
SG&A Margin	29.19	29.43	30.86	31.72	31.74
EBITDA Margin %	23.54	22.28	19.15	16.39	16.71
EBITA Margin %	19.93	18.26	14.58	11.31	11.23
EBIT Margin %	18.96	17.38	13.69	10.48	10.3
Income From Continuing Operations Margin %	145.28	-129.45	-23.86	-71.86	29.42
Net Income Margin %	145.28	-129.45	-23.86	-71.86	29.42
Net Avail. For Common Margin %	145.28	-129.45	-23.86	-71.86	29.42
Normalized Net Income Margin	12.17	11.19	10.05	7.49	7.72
Levered Free Cash Flow Margin	16.76	1.63	4.65	7.05	9.93
Unlevered Free Cash Flow Margin	16.8	2.48	5.81	8.24	11.12
Asset Turnover
Asset Turnover	0.19	0.18	0.21	0.24	0.26
Fixed Assets Turnover	4.21	4.01	3.81	3.63	3.69
Receivables Turnover (Average Receivables)	6.93	6.1	5.43	5.45	5.66
Inventory Turnover (Average Inventory)	2.1	1.91	1.65	1.54	1.65
Short Term Liquidity
Current Ratio	2.92	5.55	5.83	6.48	5.62
Quick Ratio	1.9	4.04	4.03	4.55	3.89
Operating Cash Flow to Current Liabilities	0.96	0.34	0.72	0.97	1.03
Days Sales Outstanding (Average Receivables)	52.64	59.8	67.2	67.13	64.51
Days Outstanding Inventory (Average Inventory)	173.44	191.04	220.67	237.38	220.94
Average Days Payable Outstanding	42.55	36.61	39.21	41.85	37.58
Cash Conversion Cycle (Average Days)	183.53	214.23	248.66	262.66	247.87
Long Term Solvency
Total Debt/Equity	1.63	14.44	16.08	20.93	18.58
Total Debt / Total Capital	1.61	12.62	13.85	17.3	15.67
LT Debt/Equity	1.36	14.05	15.61	20.27	18.08
Long-Term Debt / Total Capital	1.34	12.28	13.45	16.76	15.24
Total Liabilities / Total Assets	23.11	28.78	28.93	29.85	29.53
EBIT / Interest Expense	357.27	12.78	7.4	5.5	5.43
EBITDA / Interest Expense	475.91	17.81	11.63	10.02	10.17
(EBITDA - Capex) / Interest Expense	398.02	14.85	8.46	6.64	6.96
Total Debt / EBITDA	0.3	2.05	2.44	2.8	2.78
Net Debt / EBITDA	-0.88	-0.59	-0.35	-0.59	-0.31
Total Debt / (EBITDA - Capex)	0.36	2.45	3.36	4.24	4.06
Net Debt / (EBITDA - Capex)	-1.05	-0.71	-0.48	-0.89	-0.46
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.81	-4.12	-4.67	-3.92	0.65
Gross Profit, 1 Yr. Growth %	15.85	-5.69	-8.77	-3.36	-3.59
EBITDA, 1 Yr. Growth %	25.22	-11.16	-18.03	-13.05	-2.09
EBITA, 1 Yr. Growth %	32.77	-13.75	-23.88	-19.75	-6.57
EBIT, 1 Yr. Growth %	34.74	-13.83	-24.88	-20.37	-7.95
Earnings From Cont. Operations, 1 Yr. Growth %	11.55	-185.27	-82.43	189.38	-141.2
Net Income, 1 Yr. Growth %	11.55	-185.27	-82.43	189.38	-141.2
Normalized Net Income, 1 Yr. Growth %	40.97	-13.5	-14.42	-23.39	-3.16
Diluted EPS Before Extra, 1 Yr. Growth %	11.38	-186.48	-82.08	199.56	-142.61
Accounts Receivable, 1 Yr. Growth %	0.98	16.79	-1.14	-7.46	1.79
Inventory, 1 Yr. Growth %	-8.04	25.7	8.51	-2.63	-2.54
Net Property, Plant and Equip., 1 Yr. Growth %	0.32	-5.15	6.5	-4.85	3.09
Total Assets, 1 Yr. Growth %	37.03	-24.15	-8.91	-23.86	12.95
Tangible Book Value, 1 Yr. Growth %	39.17	-32.16	-9.8	-26.75	14.22
Common Equity, 1 Yr. Growth %	38.33	-29.74	-9.09	-24.85	13.46
Cash From Operations, 1 Yr. Growth %	14.11	-70.96	92.85	21.42	16.92
Capital Expenditures, 1 Yr. Growth %	22.12	-15.67	38.92	5.68	-4.83
Levered Free Cash Flow, 1 Yr. Growth %	24.45	-91.32	2.11K	69.27	32.59
Unlevered Free Cash Flow, 1 Yr. Growth %	20.52	-86.81	427.02	53.52	28.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.44	4.92	-4.4	-4.3	-1.66
Gross Profit, 2 Yr. CAGR %	15.11	4.44	-7.24	-6.2	-3.1
EBITDA, 2 Yr. CAGR %	37.5	5.58	-14.65	-17.63	-8.15
EBITA, 2 Yr. CAGR %	51.69	6.79	-18.96	-24.38	-13.71
EBIT, 2 Yr. CAGR %	55.33	7.5	-19.53	-25.34	-14.68
Earnings From Cont. Operations, 2 Yr. CAGR %	55.38	-2.48	-61.3	-28.7	9.2
Net Income, 2 Yr. CAGR %	55.38	-2.48	-61.3	-28.7	9.2
Normalized Net Income, 2 Yr. CAGR %	55.82	10.07	-13.96	-21.38	-13.81
Diluted EPS Before Extra, 2 Yr. CAGR %	55.31	-1.87	-60.64	-26.74	12.98
Accounts Receivable, 2 Yr. CAGR %	3.86	8.6	7.45	-4.36	-2.95
Inventory, 2 Yr. CAGR %	1.63	7.52	16.79	2.79	-2.58
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.39	-1.01	0.51	0.66	-0.96
Total Assets, 2 Yr. CAGR %	48.98	2.02	-16.87	-16.72	-7.27
Tangible Book Value, 2 Yr. CAGR %	56.34	-2.76	-21.77	-18.71	-8.53
Common Equity, 2 Yr. CAGR %	54.1	-1.35	-20.08	-17.34	-7.66
Cash From Operations, 2 Yr. CAGR %	19.74	-42.35	-25.17	53.02	19.15
Capital Expenditures, 2 Yr. CAGR %	10.73	1.92	8.23	21.16	0.29
Levered Free Cash Flow, 2 Yr. CAGR %	24.55	-67.36	-49.42	694.88	43.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	21.88	-60.35	-43.54	181.53	36.05
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.48	6.63	1.62	-4.24	-2.68
Gross Profit, 3 Yr. CAGR %	10.72	7.66	-0.16	-6.06	-5
EBITDA, 3 Yr. CAGR %	27.57	19.71	-2.96	-15.71	-11.37
EBITA, 3 Yr. CAGR %	38.02	26.45	-4.62	-21.2	-17.02
EBIT, 3 Yr. CAGR %	42.06	28.47	-4.61	-21.9	-17.99
Earnings From Cont. Operations, 3 Yr. CAGR %	126.46	27.29	-44.92	-24.32	-40.61
Net Income, 3 Yr. CAGR %	126.46	27.29	-44.92	-24.32	-40.61
Normalized Net Income, 3 Yr. CAGR %	43.39	28.87	1.21	-19.06	-13.77
Diluted EPS Before Extra, 3 Yr. CAGR %	126.48	27.86	-44.33	-22.57	-38.85
Accounts Receivable, 3 Yr. CAGR %	2.57	8	5.25	2.23	-2.35
Inventory, 3 Yr. CAGR %	-0.67	9.09	7.85	9.92	0.98
Net Property, Plant and Equip., 3 Yr. CAGR %	11	-1.04	1.43	-1.31	1.47
Total Assets, 3 Yr. CAGR %	46.87	19.02	-1.76	-19.27	-7.82
Tangible Book Value, 3 Yr. CAGR %	52.73	18.42	-5.17	-23.47	-8.95
Common Equity, 3 Yr. CAGR %	50.36	18.66	-4	-21.7	-8.14
Cash From Operations, 3 Yr. CAGR %	31.99	-24.84	-13.78	-12.07	39.89
Capital Expenditures, 3 Yr. CAGR %	-2.37	4.61	13.01	7.38	11.79
Levered Free Cash Flow, 3 Yr. CAGR %	54.47	-47.54	-33.77	-28.07	347.52
Unlevered Free Cash Flow, 3 Yr. CAGR %	49.17	-40.55	-29.42	-24.28	120.81
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.16	5.34	3.13	2.11	0.29
Gross Profit, 5 Yr. CAGR %	7.87	5.68	3.12	1.87	-1.35
EBITDA, 5 Yr. CAGR %	18.7	15.7	9.07	2.94	-5.07
EBITA, 5 Yr. CAGR %	25.89	22.82	11.94	2.77	-8.36
EBIT, 5 Yr. CAGR %	30.04	26.16	13.6	3.21	-8.77
Earnings From Cont. Operations, 5 Yr. CAGR %	177.08	97	11.76	0.95	-27.58
Net Income, 5 Yr. CAGR %	177.08	97	11.76	0.95	-27.58
Normalized Net Income, 5 Yr. CAGR %	32.92	29.49	17.34	5.59	-5.08
Diluted EPS Before Extra, 5 Yr. CAGR %	175.85	97.33	12.52	2.32	-26.11
Accounts Receivable, 5 Yr. CAGR %	2.61	1.25	4.5	2.88	1.89
Inventory, 5 Yr. CAGR %	1.74	3.87	5.98	6.53	3.55
Net Property, Plant and Equip., 5 Yr. CAGR %	7.32	6.61	7.31	-0.36	0.47
Total Assets, 5 Yr. CAGR %	35.79	25.87	16.99	3.18	-4
Tangible Book Value, 5 Yr. CAGR %	46.44	31.59	16.9	1.87	-6.53
Common Equity, 5 Yr. CAGR %	39.59	26.83	16.8	2.68	-5.48
Cash From Operations, 5 Yr. CAGR %	24.89	13.3	5.6	-0.12	-1.87
Capital Expenditures, 5 Yr. CAGR %	-3.1	0.26	3.83	10.94	7.74
Levered Free Cash Flow, 5 Yr. CAGR %	33.25	-0.81	-1.33	-10.55	-9.72
Unlevered Free Cash Flow, 5 Yr. CAGR %	30.37	15.96	0.97	-8.54	-8.24